Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

April 16, 2019

CELGENE CORPORATION v. SUN PHARMACEUTICAL INDUSTRIES, INC. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 07, 2020

    Sun Pharma Must Face Celgene's Suit Over Generic Revlimid

    Sun Pharma can't get out of Celgene's suit over a proposed generic version of the blockbuster cancer medication Revlimid, even though the patents in question aren't listed in the FDA's Orange Book, a New Jersey judge ruled Monday.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login